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The presence of meconium in amniotic fluid is a serious sign of fetal distress which leads to an increase in neonatal mortality [1]. Even in women who are at very low risk 
for obstetric complications, meconium-stained amniotic fluid 
(MSAF) is common and it is associated with a 5-fold increase in 
perinatal mortality as compared with low-risk patients with clear 
amniotic fluid [2]. The incidence of MSAF occurs in 10–15% of 
live birth. 5% of babies born through MSAF developed meconium 
aspiration syndrome (MAS) and mortality due to MAS occurs 
in 3–5% of neonates [3]. Meconium passage increases after 37 
weeks of gestation; MSAF is associated with higher rates of 
cesarean delivery [1].
Aspiration of meconium can occur in utero, during birth, 
or after birth. Causes of the passage of meconium in utero 
are – (a) Post-term fetus with increasing motilin levels and normal 
gastrointestinal function, (b) vagal stimulation produced by cord 
compression, (c) in utero fetal stress [4], and (d) maternal and 
fetal factors such as hypertension, gestational diabetes mellitus 
(GDM), chronic respiratory or cardiovascular diseases, post-
term pregnancy, pre-eclampsia, eclampsia, oligohydramnios, 
intrauterine growth restriction, and poor biophysical profile [5].
Chronic or acute hypoxia, acidosis, and infection can lead to 
severe MAS [4]. The study was carried out to determine the risk 
factors, clinical profile, and outcome of the neonates born through 
MSAF.
MATERIALS AND METHODS
A prospective observational study was conducted from February 
2018 to October 2018 at a neonatal unit of a tertiary care hospital, 
Vadodara. All the neonates delivered with MSAF were included 
in the study after obtaining Scientific Review Committee on 
Human Research of the hospital approval. The delivery of all 
the meconium-stained liquor babies was attended by trained 
personnel in Neonatal Resuscitation Program (NRP) and detailed 
antenatal history such as pregnancy-induced hypertension, pre-
eclampsia, and GDM, and natal history like fetal distress were 
taken. Apgar scoring was done in all newborns with MSAF. 
According to the requirement, resuscitation was done for all 
the babies. Only initial steps of resuscitation were required for 
active and vigorous babies; otherwise, resuscitation was done 
as per the general guidelines. After resuscitation, all the babies 
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were shifted to neonatal intensive care unit for further observation 
and monitoring. Detailed general examination and systemic 
examination were done in all babies with MSAF.
Routine investigations such as complete blood count and 
C-reactive protein were done in all patients. The blood culture was 
sent selectively for those patients who had clinical symptoms, risk 
factors for sepsis those who developed any complications. Chest 
X-ray was done in non-vigorous babies and in those who developed 
respiratory difficulty after birth. In patients with severe MAS and 
persistent pulmonary hypertension of newborn (PPHN), arterial 
blood gas (ABG) analysis was also done. PPHN was defined 
by both clinically and by performing echocardiography (Echo). 
Severe PPHN was defined by Grade III tricuspid regurgitation 
(TR) in Echo. Development of respiratory complications and 
non-respiratory complications such as convulsion, sepsis, and 
shock was monitored in all patients. Echo was done in all patients 
with suspected PPHN; severe PPHN (Grade III TR) was noted in 
42 babies. The different treatment modalities used for the patients 
(oxygen support, ventilation, antibiotics, and vasopressors) 
were noted. Finally, the outcome of the patients in the form of 
discharge or expiry was noted. Duration of stay in the hospital 
in all discharged and expired babies were noted. Age at death of 
expired cases was also noted.
The relevant data were collected and tabulated in Microsoft 
Excel sheet. All the variables were analyzed with the help of the 
Chi-square test and Fisher’s exact test. Significance was noted 
when p<0.05.
RESULTS
A total of 606 neonates delivered through MSAF were enrolled 
in the present study. Of 606 cases, 553 cases were of >37 weeks 
gestation. In the study population, 51.3% were male and 48.6% 
were female with a male:female ratio of 1.05:1. Of 606 cases, 385 
cases were >2.5 kg and 517 cases were appropriate for gestational 
age (AGA). There were 65.8% of cases from the rural area with 
a rural:urban ratio of 1.9:1 and 8 patients were from the tribal 
community. A total of 374 (61.7%) neonates were delivered 
through lower segment cesarean section (LSCS) method in this 
study.
Of 606 neonates, 568 (93.7%) MSAF babies were vigorous 
and 38 (6.2%) babies were non-vigorous. Fetal distress was 
present in 144 (23.7%) babies, of which 30 were non-vigorous. 
Fetal distress is defined by non-stress test as <2 accelerations 
in 40 min. The most common risk factor associated was pre-
eclampsia, which was present in 5.9% of the cases. In this study, 
2.8% of the cases had oligohydramnios and 1.5% of the cases had 
prolonged labor as the risk factor (Table1).
In the study population, 58.2% of babies developed respiratory 
distress after birth and other morbidities associated were 
convulsion in 2.1% of cases, sepsis in 16.8% of cases, shock in 
11.8% of cases, hypoxic-ischemic encephalopathy (HIE) in 2.8% 
of cases, hyperbilirubinemia in 7.9% of cases, and hypoglycemia 
in 1 baby (Table 2). As per Apgar scoring, 45 babies had birth 
asphyxia. We had not done cord ABG to know birth asphyxia. 
HIE developed in 17 babies; there was no relation with hepatitis 
B surface antigen positivity and MSAF.
Blood culture was positive in only 4.9% of cases. Blood 
culture was sent only for those patients who had risk factors, 
clinical sepsis, and in those with respiratory distress.
MAS developed in 170 (28%) babies, of which 73 (42.9%) 
babies expired; these expired babies had severe MAS. Of 42 
babies with PPHN, 34 (80%) babies expired. Of 2 neonates 
with pneumothorax, 1 (50%) baby expired, and of 7 babies with 
pulmonary hemorrhage (pulmonary hemorrhage is a complication 
of MAS), all of them (100%) expired. High-frequency oscillatory 
ventilation was not used in the setup of the current study due to 
non-availability of the same.
In our study, 32.5% of babies required antibiotics; antibiotics 
were given to all patients who had risk factors and those who 
were septic screen positive. Inotropes were given to 14.3% 
of babies, 7.2% of them required sildenafil, and 32 patients 
required vasopressor support in the form of milrinone for the 
treatment. Conventional mechanical ventilation was used in all 
the 121(19.9%) patients who required mechanical ventilation; of 
which, 73 (12%) expired. Most of the babies were started with 
intermittent positive-pressure ventilation (PPV) mode initially 
and then changed over to synchronized intermittent mandatory 
ventilation (IMV) in babies who improved. The babies who 
deteriorated were put on IMV mode of ventilation. In our study, 
of 606 neonates, 528 (87.1%) babies were discharged without 
Table 1: Distribution of risk factors in MSAF delivered babies
Risk factor n (%)
Prolonged labor 10 (1.5)
Oligohydramnios 17 (2.8)
Pre-eclampsia 36 (5.9)
Anemia 3 (0.4)
HBsAg positive 8 (1.3)
Heart disease 1 (0.1)
Fetal distress 144 (23.7)
Polyhydramnios 4 (0.6)
GDM 1 (0.1)
Hyperthyroidism 2 (0.3)
GDM: Gestational diabetes mellitus, MSAF: Meconium-stained amniotic fluid, 
HBsAg: Hepatitis B surface antigen
Table 2: Distribution of morbidity profile
Morbidity profile Frequency (%)
Respiratory distress 353 (58.2)
PPHN 42 (6.9)
Pneumothorax 2 (0.3)
Convulsion 13 (2.1)
Sepsis 102 (16.8)
Shock 72 (11.8)
HIE 17 (2.8)
Hypoglycemia 1 (0.1)
Hyperbilirubinemia 48 (7.9)
PPHN: Pulmonary hypertension of newborn, HIE: Hypoxic-ischemic 
encephalopathy
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developing MAS or any of its complications, 73 (12%) babies 
expired, and 5 babies left against medical advice. Of 72 neonates 
with Apgar score <7 at 1 min, 38 (52.7%) neonates expired and of 
34 neonates with <7 Apgar at 5 min, 26 (76.4%) expired, which 
shows a significant statistical correlation between Apgar score <7 
and expiry with p=0.02. Of 568 vigorous babies, 526 (92.6%) of 
them got discharged and of 38 non-vigorous babies, 36 (94.7%) 
babies expired, which shows a significant statistical correlation 
between non-vigorous babies and expiry with p<0.0001 (Table 3). 
In the delivery room, of all MSAF babies in the vigorous category, 
all the babies were given routine care only. In the non-vigorous 
category, all of the babies (38) required intubation with PPV in 
the delivery room itself and tracheal suctioning was not done in 
any of the babies.
Of 568 vigorous babies, 42 developed PPHN and expired. Of 
38 non-vigorous babies, 36 developed severe MAS and PPHN 
and expired. These babies were resuscitated as per NRP protocol, 
but subsequently, they expired due to severe MAS.
Of 122 neonates who required mechanical ventilation, 73 
(59.8%) babies expired and 99.3% of neonates who did not 
require mechanical ventilation were discharged, which shows 
a significant statistical correlation between the requirement of 
mechanical ventilation and their outcome with p<0.00001. The 
neonates (95.5%) who required oxygen prongs and 96.3% of 
neonates who required oxygen hood were discharged and 86% 
of the neonates who did not require oxygen prongs and 79.4% 
of neonates who did not require oxygen hood were discharged. 
Most of the neonates who required oxygen were discharged. 
There was 13% expiry in neonates who did not require oxygen 
prongs and 20.2% expiry in neonates who did not require oxygen 
hood because these babies were directly intubated and required 
oxygen through PPV and not through oxygen prongs or hood 
box; hence, they expired due to the disease. They did not wean 
off from mechanical ventilation. High flow nasal cannula was 
not available in our setup. Of 121 MAS patients who required 
mechanical ventilation, 59.5% expired and 38.8% discharged. 
All MAS patients who did not require mechanical ventilation 
were discharged, which shows a significant statistical correlation 
between mechanical ventilation in MAS patients and their expiry 
with p<0.00001.
Of 87 babies who required inotropes, 82% of them along 
with 81.8% of neonates who required sildenafil and 84.3% of 
neonates who required vasopressor in the form of milrinone 
expired. A total of 83.9% of the patients stayed for <7 days in 
the hospital, of this 85% were discharged and 14% expired. 
Only 16% of the patients stayed for >7 days, of which 94% were 
discharged and 1% expired. In this study, 98.6% of neonatal 
deaths occurred within 7 days and only one patient expired on 
the 9th day of life.
DISCUSSION
Chandran et al. found 83% of MSAF neonates after 37 weeks 
of gestation which matches with our study. The same study also 
showed a similar gender distribution pattern of 51% of males 
and 49% of females, which is almost similar to our study [6]. 
The study done by Ramakishore et al. showed that 78% of the 
neonates were >2.5 kg, which is higher than our study [7]. The 
study done by Joseph  et al. showed that MSAF was more in small 
for gestational age (SGA) babies who do not match with our 
study [8]. In our study, AGA babies associated more with MSAF. 
In our study, 68 (11.2%) babies were SGA and 517 (85.3%) were 
AGA with MSAF. The study done by Chaudhary et al. showed 
that 45 patients (54.2%) delivered by LSCS and 38 (45.7%) 
babies were delivered by vaginal delivery, which is almost similar 
to our study [9]. The study done by Sadaf et al., Pakistan, 2008, 
had a similar 5% of cases with preeclampsia [1]. However, the 
study done by Mundhra  et al., 2011, reported 16.97% of cases 
with pre-eclampsia [2]. This study also reported 21.81% of cases 
with the MSAF having fetal distress, which is similar to our study.
The study done by Divia et al. showed that respiratory distress 
present in 8.4% cases, birth asphyxia in 15.5% cases and sepsis 
in 2.42% cases, which does not match with our study [10]. Birth 
asphyxia was there in 45 (7.4%) babies as per Apgar scoring. 
Cord ABG was not done in our study. The study done by Singh  
et al. showed that 9.6% of patients had positive blood culture 
which does not match with our study [11]. The study done by 
Harerimana et al. showed inotropic requirement in 52.8% of 
patients and sildenafil in 12.5% of patients, which does not match 
with our study [12]. Echo was done in all patients with suspected 
PPHN; severe PPHN (Grade III TR) was noted in 42 babies. 
The study done by Chaudhary et al. showed 81.9% of patients 
discharged and 15.6% babies expired which is similar to our 
study [9] The study done by Harerimana et al. showed that there 
was no statistical correlation between discharge and expiry with 
Apgar score at 5 min with p=0.95, which does not match with 
our study [12]. The study done by Viraraghavan et al. showed 
that mortality was significantly higher in the non-vigorous than 
vigorous neonates (p<0.001). This matches with our study [13].
The study done by Chaudhary et al. showed that of 83 MAS 
babies, 68 babies (81.93%) were treated conservatively and 
15 babies (18.07%) were ventilated. Among these 15 ventilated 
babies, only two babies were saved from death while the other 13 
babies died. This finding was almost similar to our study [9]. In our 
study, of 568 vigorous babies, 10.7% developed severe MAS later 
on and required PPV and then died. Of 38 non-vigorous babies, 
94.7% developed severe MAS and died. The FiO2 requirement 
was high in these babies and they required FiO2 of > 80%.
The study done by Harerimana et al. showed that of 38 
patients that required inotropes, 72% expired and 42% discharged, 
i.e., the use of inotropes was associated with poor outcome. This 
is almost similar to our study. The same study also showed that 
of 20 patients who required vasodilators, 40% expired and 23% 
discharged, which does not match with our study [12]. In our 
study, more patients stayed for <7 days in the hospital because 
Table 3: Correlation between vigorousity and outcome
n Discharged Expired p-value
Vigorous 568 526 42 <0.0001
Non-vigorous 38 2 36
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most of the patients who did not develop MAS were discharged 
before 7 days and most of the expiry was within 7 days. The 
study done by Harerimana et al. showed that hospital stay was 
longer in patients who were discharged after developing any of 
the respiratory complications, which is similar to our study [12]. 
In our study, patients who required <7 days of hospital stay 
include all expired cases except one, and all MSAF delivered 
babies without any complications. Those babies without any 
complications were discharged within 72 h of life. Most of the 
babies who required >7 days of hospital stay were discharged 
after treating the complications developed due to MSAF and only 
one baby expired in this category. The study done by Singh et al. 
showed that most neonatal deaths occurred between 1 and 7 days, 
which are similar to our study [11].
CONCLUSION
There is a significant association between <7 Apgar score and 
non-vigorous babies at birth and death. Mortality is more in 
patients with severe MAS and PPHN. The requirement of 
mechanical ventilation is also associated with more number of 
deaths in MSAF babies. Reduction in maternal risk factors such 
as pre-eclampsia, in utero transfer to higher centers, and proper 
monitoring of high-risk pregnancies, and timely interventions 
such as resuscitation, early detection of complications, and proper 
management can reduce the morbidities and mortalities occur due 
to MSAF.
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